Wednesday, October 31, 2018

Dr Reddy#39;s Labs announces generic version of Straterra in US market

Dr Reddy#39;s Labs announces generic version of Straterra in US market The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equivalent of Eli Lilly and Company#39;s Straterra, Dr Reddy#39;s Laboratories said in a statement.

from Moneycontrol Business News https://ift.tt/2Q8mei6

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...